Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 10:02 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 70 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Asperger's Syndrome Clear all

Conditions: Autism, Pervasive Development Disorder, Asperger's Disorder, Attention Deficit Hyperactivity Disorder
Interventions: atomoxetine, Placebo, Parent Management Training; Drug · Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 5 Years to 14 Years
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 3
States / cities: Rochester, New York • Columbus, Ohio • Pittsburgh, Pennsylvania

Conditions: Autism, Asperger's Syndrome, Generalized Anxiety Disorder, Social Phobia, Separation Anxiety Disorder, Obsessive-compulsive Disorder
Interventions: Cognitive-behavioral therapy, Treatment as Usual; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 7 Years to 11 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: St. Petersburg, Florida

Conditions: Genetic Disorder, Asperger Disorder, Autism Spectrum Disorder, Fragile X Syndrome, Developmental Delay
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 1 Year to 99 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Attention-deficit/Hyperactivity Disorder, Autism Spectrum Disorder
Interventions: Methylphenidate extended-release liquid formulation; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 40 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Autistic Disorder, Asperger Syndrome, Anxiety Disorders
Interventions: Cognitive-behavioral therapy; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 7 Years to 11 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Autism, Asperger's Syndrome, Pervasive Developmental Disorder Not Otherwise Specified, Generalized Anxiety Disorder, Social Phobia, Separation Anxiety Disorder, Obsessive-compulsive Disorder
Interventions: Cognitive Behavioral Therapy, Treatment as usual; Other
Lead sponsor: University of South Florida; Other
Eligibility: 11 Years to 16 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: St. Petersburg, Florida

Conditions: Autism Spectrum Disorder, Autistic Disorder, Active Autistic Disorder, Autism, Asperger Syndrome, PDD-NOS, Social Communication Delay, Mixed Expressive Receptive Language Disorder, Other Symbolic Dysfunctions
Interventions: Early Achievements- Parent Coaching Intervention; Behavioral
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 18 Months to 42 Months
Enrollment: 117 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Autism Spectrum Disorder, Autism, Asperger Syndrome, PDD-NOS
Interventions: Coping Cat cognitive-behavioral therapy for anxious youth; Behavioral
Lead sponsor: Alliant International University; Other
Eligibility: 7 Years to 14 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: San Diego, California

Conditions: Autism Spectrum Disorder, Autism, Asperger Syndrome
Interventions: Transcranial magnetic stimulation; Device
Lead sponsor: Stanford University; Other
Eligibility: 12 Years to 45 Years
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 1
States / cities: Stanford, California

Conditions: Autistic Disorder, Asperger Syndrome, Child Development Disorders, Pervasive
Interventions: N-acetylcysteine, Placebo; Drug
Lead sponsor: Indiana University; Other
Eligibility: 4 Years to 12 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Autism Spectrum Disorder, Developmental Delay
Interventions: Salivary collection, Vineland Adaptive Behavior Scale-III Assessment, Medical history questionaire, Autism Diagnostic Observation Schedule -2nd edition (ADOS-2), Mullen Scales of Early Learning; Other
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 24 Months to 48 Months
Enrollment: 998 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Autism Spectrum Disorder, Intellectual Disability
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 6 Years to 65 Years
Enrollment: 164 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Autism Spectrum Disorder (ASD), Autism, Autistic Disorder, Asperger's Disorder, Asperger's, Pediatric Autism, Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Interventions: Memantine Hydrochloride (HCl); Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: 6 Years to 12 Years
Enrollment: 747 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 68
States / cities: Dothan, Alabama • Phoenix, Arizona • Tucson, Arizona + 62 more

Conditions: Autistic Disorder, Pervasive Developmental Disorder, Child Development Disorders, Pervasive, Asperger Syndrome, Autism Spectrum Disorder, Autism
Interventions: Decision Aid; Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 4 Years to 15 Years
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Autism, Asperger's Disorder, Pervasive Developmental Disorder
Interventions: Aripiprazole; Drug
Lead sponsor: Cambridge Health Alliance; Other
Eligibility: 6 Years to 17 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Medford, Massachusetts

Conditions: Autism, Asperger's Syndrome, Rett's Disorder
Interventions: Not listed
Lead sponsor: National Human Genome Research Institute (NHGRI); NIH
Eligibility: 18 Years and older
Enrollment: 324 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2015
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Autism, Autism Spectrum Disorder
Interventions: Cognitive Behavioral Therapy (CBT), Play Therapy; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 8 Years to 11 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Autism, Autism Spectrum Disorder (ASD, Asperger's Disorder, Pervasive Developmental Disorder (PDD-NOS)
Interventions: Cognitive-Behavioral Therapy (CBT) for Irritability; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 9 Years to 16 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Asperger's Disorder
Interventions: Risperidone, Magnetic Resonance Spectroscopy; Drug · Other
Lead sponsor: Augusta University; Other
Eligibility: 6 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2007
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Autism, Asperger's Disorder, Pervasive Developmental Disorder NOS
Interventions: memantine, Placebo; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Autism Spectrum Disorder, Autistic Disorder, Autism, Asperger's Syndrome, Pervasive Development Disorders
Interventions: Folinic Acid and placebo, Folinic Acid; Drug
Lead sponsor: University of Arkansas; Other
Eligibility: 3 Years to 14 Years
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Fragile X Syndrome, Autism Spectrum Disorder, Autistic Disorder, Asperger Syndrome
Interventions: Alpha Auditory Entrainment, Sham; Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 5 Years to 10 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Autism Spectrum Disorders
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 6 Years to 17 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 2
States / cities: Belmont, Massachusetts • Boston, Massachusetts

Conditions: Autistic Disorder
Interventions: diffusion tensor imaging (DTI); Other
Lead sponsor: University of Florida; Other
Eligibility: 8 Years to 12 Years · Male only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Gainesville, Florida

Search by objective public record fields.

Atomoxetine, Placebo and Parent Management Training in Autism

Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders

Pediatric Patients With Metabolic or Other Genetic Disorders

Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD

CBT for Comorbid Anxiety Disorders in Children With Autism, Asperger Syndrome, or PDD-NOS

Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism

Telehealth Parent-Implemented Intervention for Young Children With Autism Spectrum Disorder (ASD)

Cognitive-Behavioral Therapy for Children With High-Functioning Autism Spectrum Disorder and Anxiety

Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD

A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders

A Salivary miRNA Diagnostic Test for Autism

TMS for the Investigation of Brain Plasticity in Autism Spectrum Disorders

Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Shared Decision Making to Improve Care and Outcomes for Children With Autism

An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders

Predictors of Caregiver Adaptation to Pervasive Developmental Disorders

Neural and Behavioral Outcomes of Social Skills Groups in Children With Autism Spectrum Disorder (ASD)

Cognitive-Behavioral Therapy for Irritability in Adolescents With High Functioning Autism Spectrum Disorder

Janssen Asperger's MRS (Magnetic Resonance Spectroscopy Risperidone Study

Memantine in Adult Autism Spectrum Disorder

A Folinic Acid Intervention for Autism Spectrum Disorders

Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders

Magnetic Resonance Spectroscopic and Diffusion Tensor Imaging of Adolescents with Autism Spectrum Disorders

Diffusion Tensor Imaging in Autism